PLX

#3751
Protalix BioTherapeutics, Inc. Common Stock
2.1250 USD
+0.24%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
2.1150
2.1400
Rango anual
2.0300
3.1900
Cambio diario
+0.24%
Variación mensual
+0.34%
Variación en los últimos 6 meses
-27.23%
Cambio anual
-27.23%
Cierres anteriores
2.1200
Abrir
2.1250
Mínimo
2.1150
High
2.1400
Volumen
264
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Noticias